Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
1.688 Leser
Artikel bewerten:
(2)

bonyf NV: Trading Suspension

DJ bonyf NV: Trading Suspension

bonyf NV bonyf NV: Trading Suspension 24-Feb-2023 / 18:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

PRESS RELEASE Paris, 24 February 2023, 6:00 p.m. Trading suspension Ghent (Belgium), 24 February 2023, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces the suspension of the listing of its shares at the request of the company. bonyf is currently pursuing discussions with potential strategic partners and investors with the objective to strengthen the company's financial position and extend its cash runway beyond its current term (March 2023). The company requested Euronext Access in Paris to suspend trading of its shares at the commencement of trading today and it remains suspended pending further announcement. bonyf will inform the market of progress made in the evolution of its financial status. bonyf's strengths . Products with patented formulations . Produced in Switzerland compliant with stringent international quality regulations . Proven clinical efficacy . Commercial presence in 37 countries . Prospects for solid growth and rapid profitability . A fast-growing oral and dental care market About bonyf Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market. bonyf Jean-Pierre Bogaert investor@bonyf.com Press Relations CapValue info@capvalue.fr +33 1 80 81 50 00

-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: trading supsension 240223 english

=---------------------------------------------------- 
Language:    English 
Company:     bonyf NV 
         Doornzelestraat 114 D 
         9000 Gent 
         Belgium 
Phone:      +41 79 412 42 79 
E-mail:     president@bonyf.com 
Internet:    www.bonyf.com 
ISIN:      BE6333353298 
Euronext Ticker: MLBON 
AMF Category:  Inside information / Other releases 
EQS News ID:   1568531 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

1568531 24-Feb-2023 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1568531&application_name=news

(END) Dow Jones Newswires

February 24, 2023 12:00 ET (17:00 GMT)

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2023 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.